Cargando…
Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non–small cell lung cancer
Studies have shown cell-free microRNA (miRNA) circulating in the serum and plasma with specific expression in cancer, indicating the potential of using miRNAs as biomarkers for cancer diagnosis and therapy. This study was to investigate whether plasma miRNA-21 (miR-21) can be used as a biomarker for...
Autores principales: | Wei, Juan, Gao, Wen, Zhu, Cheng-Jun, Liu, Yi-Qian, Mei, Zhu, Cheng, Ting, Shu, Yong-Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sun Yat-sen University Cancer Center
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013415/ https://www.ncbi.nlm.nih.gov/pubmed/21627863 http://dx.doi.org/10.5732/cjc.010.10522 |
Ejemplares similares
-
MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
por: Shen, Hua, et al.
Publicado: (2016) -
Identification of plasma microRNA-22 as a marker for the diagnosis,
prognosis, and chemosensitivity prediction of osteosarcoma
por: Diao, Zhen-bin, et al.
Publicado: (2020) -
Circulating MicroRNA-21, MicroRNA-23a, and MicroRNA-125b as Biomarkers for Diagnosis and Prognosis of Burkitt Lymphoma in Children
por: Li, Jun, et al.
Publicado: (2016) -
Plasma microRNAs as potential biomarkers for non-small-cell lung cancer
por: Shen, Jun, et al.
Publicado: (2011) -
MicroRNA 145 enhances chemosensitivity of glioblastoma stem cells to demethoxycurcumin
por: Qian, Chunfa, et al.
Publicado: (2019)